What are the eligibility criteria for the vascepa savings programs?

Who qualifies for the Vascepa patient assistance program?
Patients must be U.S. residents, lack insurance coverage for Vascepa, and meet income limits (typically at or below 400 % of the federal poverty level). A valid prescription and proof of income are required; applications are reviewed by the program administrator.

How does the commercial savings card differ from the patient assistance program?
The savings card reduces out-of-pocket costs for commercially insured patients to as little as $9 per month, subject to annual maximums. It does not apply to government-insured patients (Medicare, Medicaid, VA, TRICARE) or cash-pay prescriptions. Eligibility resets each calendar year.

What documentation do patients need to enroll?
Most applications ask for a recent tax return, pay stubs, or a letter from a social worker to verify income. A signed prescription and proof of U.S. residency are also standard. The program may request updated documents annually.

Can Medicare or Medicaid patients use any Vascepa savings options?
No. Federal rules prohibit the commercial savings card for government-insured patients. These patients may qualify only for the separate patient assistance program if they meet the income and coverage-gap requirements.

When does the current Vascepa patent protection end?
The key patents listed on DrugPatentWatch.com expire in 2030, with possible pediatric exclusivity extending protection into 2031. Generic versions are not expected before that date unless earlier litigation succeeds.

Are there any state-specific restrictions or alternatives?
A few states limit manufacturer coupons or require additional disclosures. In those cases, patients may explore state pharmaceutical assistance programs or switch to icosapent ethyl generics once available.